Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis (Q38232998)

31 August 2017

title

Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis (English)

1 reference

31 August 2017

1 reference

0 references

Jason Lee Johnson

1

0 references

publication date

22 July 2014

1 reference

31 August 2017

published in

Cardiovascular Research

1 reference

31 August 2017

volume

103

1 reference

31 August 2017

issue

4

1 reference

31 August 2017

page(s)

452-460

1 reference

Update on acute coronary syndromes: the pathologists' view

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Nitric oxide synthases: regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Role of endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Nitric oxide and the proliferation of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

p130Cas: a versatile scaffold in signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Oxidative stress oppositely modulates protein tyrosine phosphorylation stimulated by muscarinic G protein-coupled and epidermal growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Cytoskeleton-interacting LIM-domain protein CRP1 suppresses cell proliferation and protects from stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

A cysteine-rich LIM-only protein mediates regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Loss of the serum response factor cofactor, cysteine-rich protein 1, attenuates neointima formation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Intronic CArG box regulates cysteine-rich protein 2 expression in the adult but not in developing vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Regulation of cysteine-rich protein 2 localization by the development of actin fibers during smooth muscle cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Methods of accelerated atherosclerosis in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Phosphatidylinositol 3-Kinase and Calcium-Activated Transcription Pathways Are Required for VLDL-Induced Smooth Muscle Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Altered Ca2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Altered vascular smooth muscle function in the ApoE knockout mouse during the progression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Intracellular Ca(2+) remodeling during the phenotypic journey of human coronary smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Synergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca2+ -ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Smooth muscle cell apoptosis promotes vessel remodeling and repair via activation of cell migration, proliferation, and collagen synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Chronic Apoptosis of Vascular Smooth Muscle Cells Accelerates Atherosclerosis and Promotes Calcification and Medial Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Apoptotic cell death and efferocytosis in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Smooth muscle cell phenotypic switching in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Differentiation of multipotent vascular stem cells contributes to vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Smooth muscle cell plasticity: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Characterization of culprit lesions in acute coronary syndromes using coronary dual-source CT angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Nuclear factor of activated T cells mediates oxidised LDL-induced calcification of vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Wnt signalling in smooth muscle cells and its role in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Matrix metalloproteinase-2 deficiency impairs aortic atherosclerotic calcification in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Galectin-3 in macrophage-like cells exposed to immunomodulatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Galectin-3, a novel binding partner of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Implication of galectin-3 in Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Statins use and coronary artery plaque composition: results from the International Multicenter CONFIRM Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Clinical, cellular, and molecular aspects of arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

Prospective, Randomized, Double-Blind Trial Investigating the Effect of Doxycycline on Matrix Metalloproteinase Expression Within Atherosclerotic Carotid Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU171

21 January 2018

Identifiers

DOI

10.1093/CVR/CVU171

1 reference

31 August 2017

1 reference